Stay updated on Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.

Latest updates to the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed descriptions of a Phase II clinical trial for metastatic hormone receptor positive breast cancer and the addition of a new collaborator, Merck Sharp & Dohme LLC.SummaryDifference45%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Palliative Radiotherapy in BC Clinical Trial page.